Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

August 1, 2029

Study Completion Date

February 1, 2030

Conditions
HIVTobacco UseAlcohol Use Disorder
Interventions
DRUG

Cystine

Used for smoking cessation and alcohol reduction

BEHAVIORAL

Positively Smoke Free

An 8 session tailored behavioral treatment for smoking cessation and alcohol reduction

OTHER

Placebo

Matched to cystine

OTHER

Standard of Care

Standardized brief advice to quit smoking (standard of care)

Trial Locations (2)

Unknown

Mathari National Teaching and Referral Hospital, Nairobi

Riruta Health Centre, Nairobi

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Maryland

OTHER

lead

University of Chicago

OTHER